Superior Clinical and Economic Value of <scp>IL</scp> ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
Gennaro Marco Falco(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Giacomo Caldarola(Università Cattolica del Sacro Cuore), Nicoletta Di Giorgi(Agostino Gemelli University Polyclinic), Clara De Simone(IRCCS San Camillo Hospital), Maria Vittoria Cannizzaro(Agostino Gemelli University Polyclinic), Lorenzo Marcelli(University Niccolò Cusano), Marina Talamonti(Policlinico Tor Vergata), Luca Bianchi(University of Rome Tor Vergata), Marco Galluzzo(University of Rome Tor Vergata), Niccolò Gori(Università Cattolica del Sacro Cuore), Paulo Gabriel Longo(Agostino Gemelli University Polyclinic), Elena Ippoliti(Università Cattolica del Sacro Cuore), Lucia Di Nardo(Università Cattolica del Sacro Cuore)
Cited by 1
Related Papers
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea
|British Journal of Dermatology|2010|142
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis
|British Journal of Dermatology|2006|136
Familial Melanoma: Diagnostic and Management Implications
|Dermatology Practical & Conceptual|2019|107
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
|Journal of the European Academy of Dermatology and Venereology|2019|58